Determination of Heavy Metal Bioavailability in Soil: Methods, Standards, and Applications

Soil heavy metal bioavailability testing determines the fraction of metals such as cadmium, lead, arsenic, and copper that can actually be taken up by plants, soil organisms, or the human digestive system, providing far more accurate risk insight than total concentration analysis alone. This technical guide explains the principles, sample requirements, chemical extraction protocols, DGT and bioaccessibility methods, quality control, and practical applications of bioavailability determination in agriculture, remediation, and contaminated land management.

Technical Overview

Heavy metal bioavailability refers to the portion of the total metal burden in soil that is accessible for uptake by living organisms over a defined timescale. In risk assessment and remediation practice, total concentration is often a poor predictor of actual toxicity: two soils with identical total cadmium levels can differ by an order of magnitude in the cadmium accumulated by crops, depending on soil chemistry. Bioavailability testing closes this gap by quantifying the labile, mobile, or physiologically extractable fraction of metals rather than the total pool.

Bioavailability is governed by chemical speciation and soil properties. Metals exist in several operationally defined forms: water-soluble and exchangeable fractions (highly bioavailable), fractions bound to carbonates, iron–manganese oxides, and organic matter (potentially bioavailable under changing conditions), and fractions locked in the mineral lattice (largely inert). Key soil factors controlling the distribution among these pools include pH, redox potential, cation exchange capacity, organic matter content, clay mineralogy, and the concentration of amorphous iron and aluminum oxides. Aging after contamination also progressively reduces bioavailability as metals diffuse into mineral structures.

Accordingly, bioavailability determination is built on three complementary approaches: chemical extraction methods that simulate plant uptake or element mobility, dynamic sampling techniques such as diffusive gradients in thin films (DGT) that measure the resupply capacity of the soil solution, and physiologically based in vitro methods that mimic mammalian gastrointestinal digestion for human exposure assessment. Accredited third-party laboratories combine these approaches with spectroscopic instrumentation and certified reference materials to produce defensible, standards-based data.

Testing Samples

Agricultural and Greenhouse Soils

Paddy soils, upland farmland, vegetable fields, orchards, and greenhouse substrates are tested to evaluate the transfer of cadmium, lead, and arsenic into food crops and to support safe production decisions. Paddy soils in particular require attention because alternating redox conditions can sharply increase cadmium and arsenic mobility.

Industrial and Contaminated Site Soils

Soils from former smelters, electroplating facilities, metal processing plants, fuel stations, and brownfield redevelopment sites are analyzed to refine site-specific human health and ecological risk assessments, especially where direct soil ingestion by children is a concern.

Mining Soils, Tailings, and Sediments

Mine spoils, tailings, and dredged river or lake sediments are characterized to assess phytotoxicity, guide revegetation, and evaluate the long-term leaching behavior of residual metals.

Treated Soils, Amendments, and Fertilizers

Soils treated with immobilization agents (lime, biochar, phosphate amendments, iron oxides), as well as composts, sewage sludge products, and phosphate fertilizers, are tested to verify remediation performance and product safety before land application.

Typical sample handling requirements include collection with stainless steel, bamboo, or plastic tools to avoid cross-contamination; air-drying at room temperature or oven-drying below 40 °C; gentle crushing and sieving to 2 mm for extraction tests; and storage in acid-washed polyethylene containers. For DGT deployment and pore-water analysis, field-moist samples should be kept cool and analyzed promptly to preserve in situ conditions.

Testing Items

Bioavailability testing programs typically cover the following elements and parameter categories:

• Priority toxic elements: cadmium (Cd), lead (Pb), arsenic (As), mercury (Hg), chromium (Cr) including hexavalent chromium (Cr(VI))
• Phytotoxic and nutritional metals: copper (Cu), zinc (Zn), nickel (Ni), manganese (Mn), iron (Fe), cobalt (Co), molybdenum (Mo)
• Emerging contaminants of concern: thallium (Tl), antimony (Sb), beryllium (Be), vanadium (V), selenium (Se)
• Operationally defined fractions: water-soluble, exchangeable, weak-salt-extractable (CaCl2, NH4NO3), DTPA/EDTA-extractable, and BCR or Tessier speciation fractions
• Dynamic and physiological parameters: DGT-labile concentration, soil pore-water concentration, and in vitro gastrointestinal bioaccessible fraction (gastric and intestinal phases)

Testing Methods

Single-Step Chemical Extraction

Neutral salt and chelating agent extractions are the most widely used proxies for plant-available metals. A 0.01 mol/L calcium chloride solution at a 1:10 soil-to-solution ratio estimates the directly exchangeable pool and correlates well with plant uptake for Cd, Zn, and Ni. A 1.0 mol/L ammonium nitrate extraction is standardized in ISO 19730 for trace element mobility. DTPA extraction (0.005 mol/L DTPA, 0.01 mol/L CaCl2, 0.1 mol/L triethanolamine, pH 7.3), described in the Chinese agricultural standard NY/T 890, is used for available Zn, Mn, Fe, and Cu and is frequently extended to Cd, Pb, and Ni in calcareous and neutral soils. Mehlich-3 and 0.05 mol/L EDTA extractions are also applied for multi-element availability screening. Extracts are analyzed by ICP-OES or ICP-MS following performance criteria aligned with ISO 22036.

Sequential Extraction (Speciation Analysis)

Speciation schemes fractionate the total metal pool into operationally defined reservoirs of decreasing lability. The Tessier five-step protocol separates exchangeable, carbonate-bound, iron–manganese oxide-bound, organic matter and sulfide-bound, and residual fractions. The European BCR three-step protocol (now harmonized by the Standards, Measurements and Testing Programme) distinguishes an acid-soluble/exchangeable fraction, a reducible fraction, and an oxidizable fraction, followed by residual digestion with aqua regia or hydrofluoric acid. The acid-soluble fraction is generally interpreted as the immediately bioavailable pool, while reducible and oxidizable fractions represent the potentially mobilizable reserve under acidifying or reducing conditions. Quality control relies on certified reference materials such as BCR-701, with total digestion performed according to ISO 11466 or ISO 12914 for mass balance verification.

Diffusive Gradients in Thin Films (DGT)

DGT is a dynamic passive sampling technique in which a binding layer (typically Chelex resin) separated from the soil by a well-defined diffusive hydrogel accumulates labile metal species over a deployment period. The measured time-averaged flux reflects both the soil solution concentration and the solid-phase resupply capacity, which is why DGT-labile concentrations often outperform single extractions in predicting plant uptake of Cd, Cu, Ni, Zn, and Pb, particularly when kinetics of release matter. DGT is especially valuable in weakly to moderately contaminated soils where diffusion limitation controls bioavailability.

In Vitro Gastrointestinal Bioaccessibility

For human health risk assessment, physiologically based extraction tests simulate the gastric and intestinal digestion of ingested soil particles. Common protocols include the Solubility Bioaccessibility Research Consortium (SBRC) method, the Physiologically Based Extraction Test (PBET), the In Vitro Gastrointestinal method (IVG), and the Unified BARGE Method (UBM), with international guidance provided by ISO 17924. The US EPA validated in vitro assay for lead in soil (OSWER 9200.1-86) is widely used to derive site-specific relative bioavailability values, allowing risk assessors to replace the conservative default bioavailability assumption with measured data. Bioaccessibility results for Pb, As, and Cd are typically reported as the percentage of total element released in the gastric phase and, where required, the intestinal phase.

Pore Water and Isotopic Dilution Methods

Soil pore water, obtained by rhizon suction samplers or centrifugation of field-moist soil, provides the directly accessible solution-phase concentration. Stable isotope dilution techniques determine the isotopically exchangeable pool (E-value), a rigorous measure of the labile metal quantity that is independent of extraction kinetics and is increasingly used in research-grade assessments of long-term availability.

Instrumentation and Quality Assurance

Quantification is performed by inductively coupled plasma mass spectrometry (ICP-MS) for multi-element trace analysis at sub-microgram-per-liter levels, inductively coupled plasma optical emission spectrometry (ICP-OES) for higher-concentration extracts, graphite furnace atomic absorption spectrometry (GFAAS) for single-element determinations, and atomic fluorescence spectrometry (AFS) with hydride generation or cold vapor generation for As, Se, Sb, and Hg. Hexavalent chromium is determined colorimetrically after alkaline digestion following US EPA 3060A/7196A. Quality assurance measures include method blanks, duplicate extractions, matrix spikes with 80–120% recovery targets, calibrated temperature-controlled shakers (typically 22 ± 2 °C), and analysis of certified reference soils. Because extraction conditions strongly influence results, reports must always state the extraction reagent, ratio, contact time, and temperature so that data remain comparable across projects.

Applications

Bioavailability data translate directly into better environmental and regulatory decisions:

• Food safety evaluation: predicting cadmium uptake in rice and leafy vegetables and prioritizing farmland for corrective management under agricultural soil quality frameworks such as GB 15618-2018
• Site-specific human health risk assessment: replacing default oral bioavailability assumptions with measured bioaccessibility values in exposure models for brownfield redevelopment under GB 36600-2018
• Remediation verification: quantifying the reduction in labile metal fractions after stabilization or immobilization treatment, which total concentration data cannot demonstrate
• Ecological risk screening: evaluating phytotoxicity thresholds and the mobility of metals toward groundwater using leaching procedures consistent with ISO 21268
• Amendment and fertilizer management: confirming that liming, biochar, or phosphate application shifts metals into less bioavailable speciation fractions
• Scientific research: supporting studies of metal aging, rhizosphere processes, and soil–plant transfer modeling

FAQ

Why measure bioavailability instead of only total heavy metal concentration?

Total concentration quantifies the entire metal inventory but ignores chemical form. Regulatory screening and toxicity depend on the fraction that organisms can actually absorb. Bioavailability testing distinguishes the labile pool from inert forms, preventing both under-protection of receptors and unnecessary remediation of soils whose metals are effectively immobile.

Which extraction method should be selected for a project?

The choice depends on the protection goal. For crop uptake assessment on neutral to calcareous soils, DTPA is the conventional choice, while 0.01 mol/L CaCl2 or NH4NO3 (ISO 19730) suits mobility and plant correlation studies on a wide pH range. For human ingestion exposure, in vitro bioaccessibility assays such as SBRC or UBM are appropriate. For dynamic release behavior, DGT provides the strongest mechanistic link to plant uptake. Accredited third-party laboratories can advise on method selection based on soil type, contaminant, and regulatory context.

What is the difference between bioaccessibility and bioavailability?

Bioaccessibility is the fraction that is soluble and available for absorption during gastrointestinal digestion, measured chemically in vitro. Bioavailability is the fraction actually absorbed into systemic circulation, which requires in vivo studies or validated in vitro-to-in vivo extrapolation. Regulators commonly accept validated in vitro bioaccessibility data with a conservative conversion factor as a surrogate for bioavailability.

How should samples be collected and how much is required?

Composite samples of 500 g to 1 kg of sieved (<2 mm) air-dried soil are sufficient for most extraction and speciation tests. DGT deployment requires intact, field-moist soil (typically 200–400 g wet weight) kept at constant moisture for 24 hours before and during deployment. Tools, containers, and sieves should be metal-free or acid-washed, and chain-of-custody documentation should accompany every sample.

How long does bioavailability testing take?

Single-step extractions and bioaccessibility assays are typically completed within 5 to 10 working days. Sequential extraction schemes, which involve multiple staged extractions with equilibration steps, generally require 10 to 15 working days. DGT analysis requires an additional pre-equilibration and deployment period of 1 to 3 days under laboratory conditions.

How are bioavailability results interpreted against regulatory limits?

Most soil quality standards, including GB 15618-2018 and GB 36600-2018, are expressed on a total concentration basis. Bioavailability data are therefore used to refine risk characterization rather than to pass or fail a limit directly: measured bioaccessible fractions can adjust exposure estimates in human health models, while labile fractions and DGT results support agronomic interpretation and remediation performance evaluation. Interpretation should always be performed by qualified risk assessors using the extraction conditions documented in the test report.